Hers vs Maximus: Wegovy brand vs compounded semaglutide options

Quick verdict: Hers emphasizes FDA-approved Wegovy® brand medications and a personalized care team, while Maximus focuses on lower-cost compounded semaglutide via telemedicine. Choose based on whether you prioritize brand-name, non-compounded medication or lower flat pricing.

Hers vs Maximus: what each provider offers

This comparison contrasts Hers and Maximus directly across medication type, price structure, care model, availability, and membership requirements using only supplied facts.

Medication type and regulatory notes

Hers: Offers FDA-approved Wegovy® (brand-name semaglutide) and explicitly states no compounded medications. Maximus: Offers compounded semaglutide filled through trusted U.S. pharmacies and notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.

See Maximus compounded semaglutide pricing

Pricing model and membership

Hers lists Wegovy® pill from $149/mo and injectable from $199/mo and states an active Hers Weight Loss Membership is required ($39 for the first month, auto-renews at $149/month thereafter) with membership and medication billed separately. Maximus lists $132.99 per month as a low flat rate, advertises no membership fees, and describes a straightforward direct-pay model.

Care delivery and support differences

Hers promotes a personalized care team with ongoing dose check-ins and indicates prescriptions are subject to clinician review and state availability limits. Maximus emphasizes convenient telemedicine access with prescriptions approved by licensed doctors, no in-person clinic visits, and filling through U.S. pharmacies. Maximus also notes free expedited shipping and a refund if not approved for treatment.

Review Maximus telemedicine flow

Direct comparison table: Hers vs Maximus

Outcomes, claims, and evidence

Hers cites FDA-approved brand options and highlights name-brand medication with no price markups. Maximus references publications about semaglutide outcomes, claims a competitive $132.99/month rate, and notes participant study averages in supplied marketing copy. Neither provider in the supplied facts guarantees specific patient outcomes here; treatment and prescriptions remain subject to clinician review.

Who each provider is best for

Hers is framed as best for people who want FDA-approved, brand-name Wegovy® with a personalized care team and who confirm eligibility, medication, total cost, renewal terms and state availability before enrollment. Maximus is framed as best for cost-driven patients who want a low flat rate, telemedicine access, and compounded semaglutide filled through trusted U.S. pharmacies, noting it is a smaller platform with a thinner public track record.

Conclusion: Hers vs Maximus

Hers vs Maximus boils down to brand and regulatory status versus price and telemedicine convenience. Hers offers FDA-approved Wegovy® with a personalized care team and a membership requirement. Maximus offers a lower flat price for compounded semaglutide with telemedicine access and no membership fees. Use the differences above to decide which aligns with your priorities.

Choose Hers if you prioritize FDA-approved, brand-name Wegovy®, ongoing dose check-ins, and a structured membership care model. Choose Maximus if you prioritize lower monthly cost, no membership fees, and telemedicine with compounded medication filled via U.S. pharmacies.